And Joe and Generex know their Ii-key peptide approach
And Joe and Generex know their Ii-key peptide approach works via numerous studies, illustrating how it increases potency without serious adverse events via peer reviewed reports. As everyone wisely awaits the peptide results specific to Covid-19, we already have similar to SARS and in human studies for cancer. What we need is clearer paths for funding. That avenue has been hard won since we are on the OTC. But eventually progress in opening that runway, although its of course filled with difficulty, will happen. It’s hard to say stay patient when you’ve been a shareholder so long. But that’s the reality of delisting, struggling on otcbb, and a SEC operating in a pandemic. We aren’t Pfizer with billions. We have a management team not even raising funds to enrich their pockets- no pay for years. Every delay most blame them as if they don’t care. That’s nonsense. Let these regulatory filings happen, and funding makes progress quicker. We are closing in on that time.
10
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Mobix Labs Sees Remarkable Revenue Expansion Mobix Labs, Inc. (Nasdaq: MOBX), based in Irvine, California, is making headlines with a remarkable performance in its latest fiscal year. Having achieved over 50% revenue growth, the company has undeniably marked its footprint in the advanced connectivity market, providing essential solutions for industries like aerospace,...
Continue Reading
Building Bridges: The Role of BRICS in Global South Cooperation The ongoing evolution of global politics highlights the importance of platforms like BRICS, which have become pivotal in fostering solidarity among emerging economies. The 17th BRICS Summit recently placed a strong emphasis on sustainable development, opposition to unilateral trade measures, and the need for...
Continue Reading
ATP's Notification to Copenhagen Airports A/S In a significant development, Arbejdsmarkedets Tillægspension (ATP) has notified Copenhagen Airports A/S about receiving a conditional exemption from the Danish Financial Supervisory Authority (DFSA). This exemption relates to ATP's involvement in the indirect acquisition of a controlling share in Copenhagen Airports A/S....
Continue Reading
Adecco Group's Performance Analysis for Q3 2024 The Adecco Group continues to display a robust performance even amidst challenging market conditions. Recent results for the third quarter showcase the resilience of the organization, particularly with volumes stabilizing as the market evolves. Quarterly Revenue Insights In Q3 2024, Adecco reported a 5% year-over-year...
Continue Reading
An Alternative Approach to Growth in the Mining Sector In a market where industry giants like BHP and Rio Tinto are actively pursuing mergers and acquisitions, Freeport-McMoRan (NYSE: FCX) is choosing a different path. The company is concentrated on fostering organic growth, prioritizing production increment over expensive acquisitions. Production Expansion Across...
Continue Reading
